Connect with us

News

Wa’ed Ventures Pledges $100M For Early-Stage AI Startup Funding

The move aligns with Saudi Arabia’s plans to become a global AI hub, as the Kingdom anticipates a $135 billion boost to GDP by 2030.

Published

on

wa'ed ventures pledges $100 million for early stage ai startup funding

Wa’ed Ventures, a wholly-owned subsidiary of Aramco, has announced a $100 million allocation aimed at funding early-stage artificial intelligence (AI) startups. The move aligns with Saudi Arabia’s ambitions to establish itself as a global hub for AI innovation and is part of Wa’ed Ventures’ broader mission to nurture high-potential AI technologies.

To strengthen its investment decisions and deal-sourcing, Wa’ed Ventures has assembled an advisory board of experts with backgrounds from leading institutions such as Meta, Amazon, MIT, and Oxford University. These advisors bring a wealth of experience from sectors such as AI research, policymaking, academia, and entrepreneurship, providing critical insights and support to the fund’s investment strategy.

Anas Algahtani, Acting CEO of Wa’ed Ventures, shared: “Our strategic decision to allocate funds to AI investments is rooted in a deep understanding of the Kingdom’s growing ecosystem. By fostering innovation and supporting AI startups, we aim to accelerate the development of cutting-edge technologies that will drive economic growth, improve quality of life, and position Saudi Arabia as a global leader in Artificial Intelligence”.

As part of its active portfolio development, Wa’ed Ventures has made recent investments in Rebellions, a South Korean company specializing in AI chips, and AiXplain, a California-based provider of infrastructure for accelerated AI development. These investments reflect Wa’ed’s commitment to advancing AI applications and supporting companies that can enhance Saudi Arabia’s AI capabilities.

Also Read: Top Free AI Chatbots Available In The Middle East

Wa’ed Ventures’ AI-focused initiative not only targets the growth of local entrepreneurship but also aims to localize international AI talent and technologies, fostering a robust ecosystem that aligns with Saudi Vision 2030 goals.

A recent PwC report highlights the potential economic impact of AI on Saudi Arabia, projecting that by 2030, the country could generate $135 billion from AI-related activities, accounting for approximately 12% of its Gross Domestic Product (GDP). This puts Saudi Arabia in a favorable position within the Middle East to capitalize on the transformative power of AI.

Advertisement

📢 Get Exclusive Monthly Articles, Updates & Tech Tips Right In Your Inbox!

JOIN 23K+ SUBSCRIBERS

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

News

A Three-Clinic Network Bets Dubai Is Ready For Longevity Medicine

Longevium has enlisted nearly 100 clinicians and created an AI platform in a bid to sell biological-age tracking as a medicine, not a wellness service.

Published

on

a three-clinic network bets dubai is ready for longevity medicine

Dubai has been busily creating the scaffolding for a longevity industry, including a dedicated regulatory authority and a health market deep enough to sustain it. Now the clinics are arriving.

Longevium, a longevity clinic network, has opened three locations across the city: a flagship at Triple Seven Mall on Jumeirah 3, and branches in Jumeirah Lake Towers and Jumeirah Village Circle. Together they house a multidisciplinary team of nearly 100 physicians and specialists offering what the company bills as “a measurable medical system for longevity”.

longevity dubai clinic launch

The pitch is that longevity medicine should look less like a wellness menu and more like continuous clinical care. Each patient’s biological age assessment, laboratory results, body composition, cardiovascular risk factors, metabolic markers, and lifestyle data feed into a single profile, with a proprietary AI platform helping physicians track progress and adjust protocols against the patient’s own biomarkers.

“Healthy aging must be approached clinically through diagnostics, biomarkers, physician supervision, longitudinal tracking, and protocols tailored to the individual,” said Dr. Ksenia Butova, Longevium’s founder and CEO. “Our goal is to help patients understand their health trajectory before disease develops, and then actively change that trajectory”.

The treatment list spans peptide-based protocols, exosome therapies, stem cell approaches, GLP-1 metabolic optimization, hormone balance programs, cardiovascular prevention, and regenerative aesthetics — a model built for the entrepreneurs, executives, and international patients the clinic says want measurable results rather than generic wellness. A signature offering, Longevity Day, compresses biomarker testing, ultrasound and vascular imaging, specialist consultations, IV therapy, and a personalized optimization roadmap into a single three-hour visit.

Also Read: Dubai Certifies The World’s First Purpose-Built Air Taxi Vertiport

“Here, longevity, biotechnology, AI, prevention, and regenerative medicine are converging into a single ecosystem,” said Butova. “This is why Longevium was built in Dubai, and why we believe the UAE can become a global reference point for longevity medicine”.

The emirate established the Dubai Longevity Authority in 2026 to oversee its longevity, wellness, and advanced health sectors, and the Dubai Health Authority reported insured beneficiaries exceeding 4.9 million in 2025, up around 6.5%, with insurance claims reaching approximately 49.6 million, up around 13.5%.

Continue Reading

#Trending